The deal is sourced from Premier's own 8-K closing-announcement exhibit, filed November 25, 2025, confirming completion of the previously announced merger and referencing an earlier Form 8-K that disclosed the definitive agreement.
Perella Weinberg Partners LP served specifically as debt capital markets advisor to Patient Square, the acquirer, distinct from Patient Square's M&A financial advisors. The release states: "Kirkland & Ellis LLP served as legal counsel, Ropes & Gray served as health care legal counsel, Jefferies LLC and Santander served as financial advisors, and Perella Weinberg Partners LP served as debt capital markets advisor to Patient Square." On the target side, Goldman Sachs & Co. LLC and BofA Securities, Inc. served as financial advisors to Premier.
Wachtell, Lipton, Rosen & Katz served as legal counsel to Premier, with Cravath, Swaine & Moore LLP advising the Transaction Committee of Premier's Board specifically. Kirkland & Ellis LLP served as general legal counsel to Patient Square, with Ropes & Gray serving as dedicated health care regulatory counsel. Joele Frank served as Premier's strategic communications advisor.
The $2.6 billion aggregate transaction value and $28.25 per-share cash price are both explicitly disclosed in the closing press release. The transaction closed and Premier was delisted from Nasdaq as of November 25, 2025.
Not disclosed in the reviewed excerpt: the specific debt financing package size or structure that Perella Weinberg advised on, the identity of debt financing providers, and whether Jefferies or Santander held lead-advisor status relative to each other on the M&A side.